Full Development (Phase 3,4)

In Full Development, the project team strives to: Phase 3 – fully evaluate drug in the patient population to determine final approvable indications and conduct any final trials required for approval by regulatory agencies; Phase 4 – conduct clinical trials that might expand the indications of the drug.  Phase 4 trials often occur after registration and launch.